Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chaoju Eye Care HoldingsHKSE:02219 +3.81%93 Days Payable is 28.36 as of Dec. 2025, which is 7% above its 10-year median of 26.54. GuruFocus rates HKSE:02219 with a GF Score™ of 93/100 and a GF Value™ of HK$3.47 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Chaoju Eye Care Holdings ranks worse than 77.65% on this metric.
The historical rank and industry rank for Chaoju Eye Care Holdings's Days Payable or its related term are showing as below:
HKSE:02219'
s Days Payable Range Over the Past 10 Years
Min: 24.46 Med: 26.54 Max: 58.99
Current: 26.71
During the past 8 years, Chaoju Eye Care Holdings's highest Days Payable was 58.99. The lowest was 24.46. And the median was 26.54.
HKSE:02219's Days Payable is ranked worse than 77.65% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 57.48
vs HKSE:02219: 26.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02219 vs HCA, THC, EHC: Days Payable Comparison
For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chaoju Eye Care Holdings Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Chaoju Eye Care Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Chaoju Eye Care Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chaoju Eye Care Holdings (HKSE:02219) has a Days Payable of 28.36 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chaoju Eye Care Holdings and its competitors. This is near median its historical median of 26.54. Over the past decade, Chaoju Eye Care Holdings' Days Payable has ranged from 24.46 to 58.99. According to the industry distribution chart, Chaoju Eye Care Holdings ranks #476 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 77.7%.
Is Chaoju Eye Care Holdings' Days Payable too high?
Chaoju Eye Care Holdings' current Days Payable of 28.36 is near median its 10-year median of 26.54. Over the past 10 years, this metric has ranged from a low of 24.46 to a high of 58.99. The Healthcare Providers & Services industry median Days Payable is 57.48. Chaoju Eye Care Holdings' value of 28.36 is 50.7% below this industry median. Based on the distribution chart, Chaoju Eye Care Holdings ranks #476 out of 613 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Chaoju Eye Care Holdings has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chaoju Eye Care Holdings' Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chaoju Eye Care Holdings ranks #476 out of 613 companies for Days Payable. This places Chaoju Eye Care Holdings in the lower half of its industry. The industry median Days Payable is 57.48. Chaoju Eye Care Holdings' value of 28.36 is 50.7% below this benchmark. Historically, Chaoju Eye Care Holdings' own Days Payable has ranged from 24.46 to 58.99 over the past decade. While the company's 10-year median is 26.54 vs. the industry median of 57.48, Chaoju Eye Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.48, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chaoju Eye Care Holdings's current Days Payable of 28.36 is 50.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chaoju Eye Care Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chaoju Eye Care Holdings's current Days Payable is 28.36, which is near median its own 10-year median of 26.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chaoju Eye Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings (HKSE:02219) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.47, compared to a current price of HK$2.45 — trading 29.4% below its estimated fair value. The current Days Payable is 28.36, which is near median its 10-year median of 26.54 and 50.7% below the Healthcare Providers & Services industry median of 57.48. Chaoju Eye Care Holdings' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Chaoju Eye Care Holdings (HKSE:02219), the current Days Payable is 28.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chaoju Eye Care Holdings (HKSE:02219) Overvalued in 2026?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings stock appears to be undervalued.
The current stock price of HK$2.45 is trading 29.4% below its estimated GF Value™ of HK$3.47.
GuruFocus considers Chaoju Eye Care Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02219:
Days Payable: 28.36 (near median its 10-year median of 26.54)
GF Value™: HK$3.47 vs. price of HK$2.45 (29.4% below fair value)
Industry Position: 50.7% below the Healthcare Providers & Services median (#476 of 613)
No single metric tells the full story. See the HKSE:02219 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chaoju Eye Care Holdings Ltd is an ophthalmic medical service group in North China engaged in the provision of in-patient services, out-patient services, and sales of optical products. The company generates revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control, and the provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
93GF Score
Get the complete analysis for HKSE:02219
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02219 has been successfully added to your 
